Patents by Inventor Marc J. KAUFMAN

Marc J. KAUFMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS
    Publication number: 20170312308
    Abstract: The present invention relates generally to the fields of treating psychiatric disorders, in particular, anxiety disorders including post-traumatic stress disorder (PTSD) in subjects, e.g., human subjects, by administering a xenon and/or argon containing composition. Treatments can also employ psychotherapy in combination with administration of xenon and/or argon, alone or in combination with additional psychotherapeutic medications to treat the anxiety disorder and reduce a symptom of the anxiety disorder in the subject.
    Type: Application
    Filed: July 19, 2017
    Publication date: November 2, 2017
    Applicant: THE MCLEAN HOSPITAL CORPORATION
    Inventors: Edward G. Meloni, Marc J. Kaufman
  • Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders
    Patent number: 9737562
    Abstract: The present invention relates generally to the fields of treating psychiatric disorders, in particular, anxiety disorders including post-traumatic stress disorder (PTSD) in subjects, e.g., human subjects, by administering a xenon and/or argon containing composition. Treatments can also employ psychotherapy in combination with administration of xenon and/or argon, alone or in combination with additional psychotherapeutic medications to treat the anxiety disorder and reduce a symptom of the anxiety disorder in the subject.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: August 22, 2017
    Assignee: THE MCLEAN HOSPITAL CORPORATION
    Inventors: Edward G. Meloni, Marc J. Kaufman
  • XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS
    Publication number: 20150306136
    Abstract: The present invention relates generally to the fields of treating psychiatric disorders, in particular, anxiety disorders including post-traumatic stress disorder (PTSD) in subjects, e.g., human subjects, by administering a xenon and/or argon containing composition. Treatments can also employ psychotherapy in combination with administration of xenon and/or argon, alone or in combination with additional psychotherapeutic medications to treat the anxiety disorder and reduce a symptom of the anxiety disorder in the subject.
    Type: Application
    Filed: December 10, 2013
    Publication date: October 29, 2015
    Applicant: THE MCLEAN HOSPITAL CORPORATION
    Inventors: Edward G. MELONI, Marc J. KAUFMAN